Compare MESO & BOBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | BOBS |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | Australia | United States |
| Employees | 81 | 5950 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | N/A | N/A |
| Metric | MESO | BOBS |
|---|---|---|
| Price | $14.27 | $16.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $23.73 |
| AVG Volume (30 Days) | 175.9K | ★ 1.0M |
| Earning Date | 02-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $629.74 | $12.58 |
| Revenue Next Year | $30.65 | $7.43 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.32 | $9.74 |
| 52 Week High | $21.50 | $23.11 |
| Indicator | MESO | BOBS |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 69.15 |
| Support Level | $13.91 | $11.46 |
| Resistance Level | $16.06 | $23.11 |
| Average True Range (ATR) | 0.40 | 0.97 |
| MACD | -0.01 | 0.27 |
| Stochastic Oscillator | 47.08 | 93.40 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Bobs Discount Furniture Inc operates as a furniture retailer offering a wide variety of merchandise assortments across several categories, including upholstery, case goods, bedding, and other. The company generates the majority of its revenue from the sale of its products through its retail stores.